Ryan Pawell (Founder, Director & Chief Executive Officer) is an alumni of Y Combinator, a published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and microfluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force, National Institutes of Health, and National Cancer Institute among others.


Amy Twite, PhD (Chief Scientific Officer) is an interdisciplinary scientist who has been researching the interface of chemistry and biology for 15 years with the goal of bettering the world. Her unique education allows her to approach problems differently than chemists or biologists. Her efforts have helped bring about new avenues for human therapies and bio-based tools for model system development and resource production.


heidi hagen.jpg

Heidi Hagen is co-founder and Chief Strategy Officer at Vineti with more than 15 years experience in commercial cell therapy. Prior to this, she successfully delivered the first operation that manufactures and distributes live autologous cellular products within an 18 hour time window to oncology patients in both the United States and Europe

geoff facer.jpg

Geoff Facer, PhD is the Director of Product Development at Beckton Dickinson Genomics with more than 15 years of commercial microfluidics experience. Prior to this, he helped orchestrate the single largest patent filing of all time as Vice President of Development at Geneasys while working on a point-of-care microfluidic device for biological analysis.

Warren McKenzie, PhD MCom CMatP is an Endeavour Executive Fellow, Director of Indee Labs Australia, National Business Development Manager for the Australian National Fabrication Facility along with Founder and CEO at Advanced Alloy Holdings. He has more than 10 years of commercial scientific experience. Most recently, Warren was able to spin-out an early-stage academic technology into a revenue-stage business without investment.

todd martin.jpg

Todd Martin JD MS MIP is a Director of Eagar & Martin Patent & Trademark Attorneys with 16 years of patent experience across four continents and is licensed to practice in the United States, Australia and New Zealand. Todd was substantially involved in building the Michelson patent portfolio, which sold to Medtronic for US$1.25B and has prepared claims that were litigated in three trials resulting in judgements or settlements of at least US$100M each.

hamish hawthrone.jpg

Hamish Hawthorne is Chief Operating Officer at UpGuard. Prior to this he was CEO at Cicada Innovations and co-founded a Sydney-based angel network. Hamish has been deeply involved in the development of the Australian startup ecosystem -- particularly focused on the development of capability in the founders of technology ventures including those in the biotechnology and hardware industries.

jorge nieva.jpg

Jorge Nieva MD is a Professor of Clinical Medicine at the University of Southern California’s Keck School of Medicine with nearly 20 years of experience in the areas of oncology, hematology, gene therapy and entrepreneurship. Prior to this, he developed technologies for enumerating and characterising circulating tumour cells and served as a principal investigator for gene therapy clinical trials that were recognised by the American Society of Clinical Oncology and the National Cancer Institute for excellence in cancer clinical trials.

company progress